Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ORIC PHARMACEUTICALS, INC.

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC)
Listen to this Section


$9.52
+0.0860 ( +0.91% ) 725.8K

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.

Market Data


Open $9.52
Previous Close $9.43
Volume 725.8K
Market Cap $976.17M
Day Range $9.30 - $9.97
52 Week Range $7.23 - $14.93
Shares Outstanding 103.52M
Change % +0.91%
Net Change ▲ 0.0860
Insider Ownership -0.13%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,059,418.00

Date Type Amount Purchased Purchaser
2024-02-08 Sale -13958.00 Chacko Jacob
2024-01-03 Sale -180000.00 Multani Pratik S
2024-01-03 Sale -180000.00 Piscitelli Dominic
2024-01-03 Sale -510000.00 Chacko Jacob
2023-12-19 Sale -14042.00 Multani Pratik S
2023-12-19 Sale -14042.00 Piscitelli Dominic
2023-12-19 Sale -38667.00 Chacko Jacob

SEC Filings


Form Type Description Pages Date
8-k 8K-related 22 Nov 13, 2025
8-k 8K-related 12 Nov 13, 2025
10-q Quarterly Reports 48 Nov 13, 2025
4 Insider transactions 1 Oct 08, 2025
4 Insider transactions 1 Oct 08, 2025
4 Insider transactions 1 Oct 03, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Sep 24, 2025
10-q Quarterly Reports 50 Aug 12, 2025
8-k 8K-related 12 Aug 12, 2025

Latest News